nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Glyburide—KCNJ5—adrenal gland cancer	0.079	0.918	CrCbGaD
Gliclazide—ABCC8—Inwardly rectifying K+ channels—KCNJ5—adrenal gland cancer	0.0542	0.069	CbGpPWpGaD
Gliclazide—KCNJ11—Inwardly rectifying K+ channels—KCNJ5—adrenal gland cancer	0.0526	0.0669	CbGpPWpGaD
Gliclazide—CYP2C19—urine—adrenal gland cancer	0.0237	0.185	CbGeAlD
Gliclazide—ABCC8—Potassium Channels—KCNJ5—adrenal gland cancer	0.0214	0.0273	CbGpPWpGaD
Gliclazide—KCNJ11—Potassium Channels—KCNJ5—adrenal gland cancer	0.0208	0.0264	CbGpPWpGaD
Gliclazide—VEGFA—VEGFR1 specific signals—PRKACA—adrenal gland cancer	0.02	0.0255	CbGpPWpGaD
Gliclazide—CYP2C9—urine—adrenal gland cancer	0.0183	0.143	CbGeAlD
Gliclazide—VEGFA—adrenal cortex—adrenal gland cancer	0.0165	0.129	CbGeAlD
Gliclazide—ABCC8—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.0147	0.0187	CbGpPWpGaD
Gliclazide—VEGFA—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—adrenal gland cancer	0.014	0.0179	CbGpPWpGaD
Gliclazide—VEGFA—cardiac atrium—adrenal gland cancer	0.0136	0.107	CbGeAlD
Gliclazide—VEGFA—pituitary gland—adrenal gland cancer	0.0133	0.104	CbGeAlD
Gliclazide—VEGFA—S1P1 pathway—PTGS2—adrenal gland cancer	0.0122	0.0156	CbGpPWpGaD
Gliclazide—VEGFA—adrenal gland—adrenal gland cancer	0.0119	0.0929	CbGeAlD
Gliclazide—VEGFA—SHP2 signaling—PRKACA—adrenal gland cancer	0.0115	0.0146	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—PRKACA—adrenal gland cancer	0.0106	0.0135	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—SPARC—adrenal gland cancer	0.0105	0.0134	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—BRAF—adrenal gland cancer	0.0102	0.013	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—PRKACA—adrenal gland cancer	0.0101	0.0129	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—RB1—adrenal gland cancer	0.0101	0.0128	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.01	0.0128	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.01	0.0128	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—PRKACA—adrenal gland cancer	0.00973	0.0124	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—KCNJ5—adrenal gland cancer	0.00935	0.0119	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—IGF1R—adrenal gland cancer	0.00909	0.0116	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—KCNJ5—adrenal gland cancer	0.00907	0.0115	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—CDKN2A—adrenal gland cancer	0.00884	0.0112	CbGpPWpGaD
Gliclazide—ABCC8—pituitary gland—adrenal gland cancer	0.00879	0.0686	CbGeAlD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00877	0.0112	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—IGF2—adrenal gland cancer	0.00869	0.0111	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CDC42—adrenal gland cancer	0.00859	0.0109	CbGpPWpGaD
Gliclazide—KCNJ11—adrenal gland—adrenal gland cancer	0.00852	0.0665	CbGeAlD
Gliclazide—VEGFA—Integrins in angiogenesis—IGF1R—adrenal gland cancer	0.00851	0.0108	CbGpPWpGaD
Gliclazide—VEGFA—Endochondral Ossification—IGF1R—adrenal gland cancer	0.0084	0.0107	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.00825	0.0105	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00815	0.0104	CbGpPWpGaD
Gliclazide—ABCC8—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00813	0.0104	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00789	0.01	CbGpPWpGaD
Gliclazide—KCNJ11—Regulation of insulin secretion—GNAS—adrenal gland cancer	0.00789	0.01	CbGpPWpGaD
Gliclazide—ABCC8—adrenal gland—adrenal gland cancer	0.00785	0.0612	CbGeAlD
Gliclazide—KCNJ11—Integration of energy metabolism—PRKACA—adrenal gland cancer	0.00765	0.00974	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00733	0.00933	CbGpPWpGaD
Gliclazide—VEGFA—Platelet degranulation—IGF2—adrenal gland cancer	0.00727	0.00925	CbGpPWpGaD
Gliclazide—VEGFA—Allograft Rejection—ABCB1—adrenal gland cancer	0.00714	0.00909	CbGpPWpGaD
Gliclazide—VEGFA—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.00706	0.00898	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—PRKACA—adrenal gland cancer	0.00705	0.00897	CbGpPWpGaD
Gliclazide—VEGFA—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.00693	0.00881	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—PRKACA—adrenal gland cancer	0.00665	0.00846	CbGpPWpGaD
Gliclazide—VEGFA—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.00663	0.00844	CbGpPWpGaD
Gliclazide—ABCC8—Integration of energy metabolism—GNAS—adrenal gland cancer	0.00639	0.00814	CbGpPWpGaD
Gliclazide—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—adrenal gland cancer	0.00635	0.00808	CbGpPWpGaD
Gliclazide—KCNJ11—Integration of energy metabolism—GNAS—adrenal gland cancer	0.0062	0.00789	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00603	0.00767	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—CDC42—adrenal gland cancer	0.00598	0.00761	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—EGFR—adrenal gland cancer	0.00586	0.00745	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—CDC42—adrenal gland cancer	0.00564	0.00718	CbGpPWpGaD
Gliclazide—ALB—adrenal gland—adrenal gland cancer	0.00562	0.0439	CbGeAlD
Gliclazide—VEGFA—Heart Development—CTNNB1—adrenal gland cancer	0.00559	0.00711	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—BRAF—adrenal gland cancer	0.00546	0.00694	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00521	0.00663	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00503	0.00641	CbGpPWpGaD
Gliclazide—VEGFA—Bladder Cancer—TP53—adrenal gland cancer	0.00492	0.00626	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by TCPTP—EGFR—adrenal gland cancer	0.00478	0.00608	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NR5A1—adrenal gland cancer	0.00473	0.00602	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00467	0.00595	CbGpPWpGaD
Gliclazide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00466	0.00593	CbGpPWpGaD
Gliclazide—ALB—Lipid and lipoprotein metabolism—PRKACA—adrenal gland cancer	0.00457	0.00582	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.00454	0.00577	CbGpPWpGaD
Gliclazide—VEGFA—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00427	0.00544	CbGpPWpGaD
Gliclazide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00425	0.00541	CbGpPWpGaD
Gliclazide—Chlorpropamide—ABCB1—adrenal gland cancer	0.0042	0.0489	CrCbGaD
Gliclazide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00405	0.00516	CbGpPWpGaD
Gliclazide—VEGFA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.00394	0.00502	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CDC42—adrenal gland cancer	0.00378	0.0048	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—SPARC—adrenal gland cancer	0.00372	0.00473	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—PRKACA—adrenal gland cancer	0.00358	0.00456	CbGpPWpGaD
Gliclazide—VEGFA—SHP2 signaling—EGFR—adrenal gland cancer	0.00355	0.00452	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00354	0.00451	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00353	0.00449	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—IGF1R—adrenal gland cancer	0.00352	0.00448	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—PRKACA—adrenal gland cancer	0.00347	0.00442	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00335	0.00426	CbGpPWpGaD
Gliclazide—VEGFA—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00322	0.0041	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.00317	0.00403	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.00288	0.00367	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—MED12—adrenal gland cancer	0.00284	0.00362	CbGpPWpGaD
Gliclazide—Glyburide—ABCB1—adrenal gland cancer	0.00284	0.033	CrCbGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.00283	0.00361	CbGpPWpGaD
Gliclazide—VEGFA—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.00274	0.00349	CbGpPWpGaD
Gliclazide—VEGFA—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.00272	0.00346	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—BAD—adrenal gland cancer	0.00263	0.00335	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00262	0.00334	CbGpPWpGaD
Gliclazide—VEGFA—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.00259	0.0033	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SDHB—adrenal gland cancer	0.00257	0.00328	CbGpPWpGaD
Gliclazide—ALB—Platelet degranulation—IGF2—adrenal gland cancer	0.00257	0.00327	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SDHB—adrenal gland cancer	0.0025	0.00318	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—CDC42—adrenal gland cancer	0.00246	0.00314	CbGpPWpGaD
Gliclazide—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.00244	0.00311	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—SPARC—adrenal gland cancer	0.00241	0.00307	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—BRAF—adrenal gland cancer	0.0024	0.00305	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.00208	0.00265	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—PRKACA—adrenal gland cancer	0.00203	0.00259	CbGpPWpGaD
Gliclazide—VEGFA—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00203	0.00258	CbGpPWpGaD
Gliclazide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00194	0.00246	CbGpPWpGaD
Gliclazide—ABCC8—Neuronal System—BRAF—adrenal gland cancer	0.00193	0.00246	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00193	0.00246	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00193	0.00245	CbGpPWpGaD
Gliclazide—KCNJ11—Neuronal System—BRAF—adrenal gland cancer	0.00187	0.00238	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—RB1—adrenal gland cancer	0.00181	0.00231	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNRHR—adrenal gland cancer	0.0018	0.00229	CbGpPWpGaD
Gliclazide—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00179	0.00227	CbGpPWpGaD
Gliclazide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00176	0.00225	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CDC42—adrenal gland cancer	0.00176	0.00224	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—CTNNB1—adrenal gland cancer	0.00173	0.00221	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.00173	0.0022	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—CDC42—adrenal gland cancer	0.00172	0.00219	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00167	0.00213	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—IGF2—adrenal gland cancer	0.00166	0.00212	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—RRM1—adrenal gland cancer	0.00166	0.00211	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—SDHD—adrenal gland cancer	0.00166	0.00211	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.00165	0.0021	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00165	0.0021	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—GNAS—adrenal gland cancer	0.00165	0.0021	CbGpPWpGaD
Gliclazide—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00163	0.00207	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—RRM1—adrenal gland cancer	0.00161	0.00205	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—SDHD—adrenal gland cancer	0.00161	0.00205	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—CDKN2A—adrenal gland cancer	0.00159	0.00203	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00157	0.002	CbGpPWpGaD
Gliclazide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00157	0.002	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00156	0.00199	CbGpPWpGaD
Gliclazide—ABCC8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00153	0.00195	CbGpPWpGaD
Gliclazide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00143	0.00182	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.00139	0.00176	CbGpPWpGaD
Gliclazide—VEGFA—Focal Adhesion—EGFR—adrenal gland cancer	0.00137	0.00175	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00137	0.00174	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00127	0.00161	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MED12—adrenal gland cancer	0.00124	0.00157	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MED12—adrenal gland cancer	0.0012	0.00153	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00118	0.0015	CbGpPWpGaD
Gliclazide—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.00115	0.00146	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.00114	0.00145	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNRH1—adrenal gland cancer	0.00108	0.00137	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SPRY2—adrenal gland cancer	0.000985	0.00125	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TSHR—adrenal gland cancer	0.00096	0.00122	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—TP53—adrenal gland cancer	0.000948	0.00121	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—MEN1—adrenal gland cancer	0.000903	0.00115	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PRKACA—adrenal gland cancer	0.000902	0.00115	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—EGFR—adrenal gland cancer	0.000896	0.00114	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000895	0.00114	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—TP53—adrenal gland cancer	0.000886	0.00113	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PRKACA—adrenal gland cancer	0.000875	0.00111	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SPARC—adrenal gland cancer	0.00085	0.00108	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000833	0.00106	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SDHB—adrenal gland cancer	0.00083	0.00106	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—CTNNB1—adrenal gland cancer	0.000807	0.00103	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000804	0.00102	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.00076	0.000967	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000745	0.000948	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000733	0.000933	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—GNAS—adrenal gland cancer	0.000731	0.000931	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCB1—adrenal gland cancer	0.000718	0.000913	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PRKACA—adrenal gland cancer	0.000717	0.000913	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—GNAS—adrenal gland cancer	0.000709	0.000902	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCB1—adrenal gland cancer	0.000696	0.000886	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—PRKACA—adrenal gland cancer	0.000689	0.000877	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000679	0.000865	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000653	0.000831	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—EGFR—adrenal gland cancer	0.000639	0.000814	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000621	0.00079	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—CDC42—adrenal gland cancer	0.000609	0.000775	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF2—adrenal gland cancer	0.000587	0.000747	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000586	0.000746	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CDC42—adrenal gland cancer	0.000585	0.000744	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—GNAS—adrenal gland cancer	0.000582	0.00074	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF2—adrenal gland cancer	0.000564	0.000717	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—GNAS—adrenal gland cancer	0.000559	0.000711	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1R—adrenal gland cancer	0.000545	0.000693	CbGpPWpGaD
Gliclazide—ALB—Metabolism—RRM1—adrenal gland cancer	0.000535	0.000681	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SDHD—adrenal gland cancer	0.000535	0.000681	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000535	0.00068	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TP53—adrenal gland cancer	0.000527	0.00067	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000503	0.000641	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000494	0.000629	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—adrenal gland cancer	0.000492	0.000627	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.00048	0.000611	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.00048	0.000611	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—adrenal gland cancer	0.000477	0.000608	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TERT—adrenal gland cancer	0.000469	0.000597	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000438	0.000557	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000438	0.000557	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BAD—adrenal gland cancer	0.000408	0.000519	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MED12—adrenal gland cancer	0.000399	0.000507	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—adrenal gland cancer	0.000393	0.0005	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—adrenal gland cancer	0.000381	0.000485	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—adrenal gland cancer	0.000376	0.000479	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—BRAF—adrenal gland cancer	0.000371	0.000473	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000358	0.000456	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000356	0.000454	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000326	0.000415	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.00032	0.000407	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000292	0.000371	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PRKACA—adrenal gland cancer	0.000291	0.00037	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000284	0.000362	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000268	0.000342	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000261	0.000332	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000255	0.000325	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000238	0.000303	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GNAS—adrenal gland cancer	0.000236	0.0003	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000233	0.000296	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCB1—adrenal gland cancer	0.000231	0.000294	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EGFR—adrenal gland cancer	0.000213	0.000271	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000212	0.000269	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000208	0.000264	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000193	0.000246	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000189	0.000241	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TP53—adrenal gland cancer	0.000186	0.000237	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TP53—adrenal gland cancer	0.000179	0.000227	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—adrenal gland cancer	0.000159	0.000202	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000143	0.000181	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.00013	0.000165	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—adrenal gland cancer	0.000127	0.000161	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000114	0.000145	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000104	0.000132	CbGpPWpGaD
